NASDAQ: CVIIChurchill Capital Corp Vii Stock
$10.71+0.00 (+0%)
Updated Apr 23, 2024
CVII Price
$10.71
Fair Value Price
N/A
Market Cap
$980.65M
52 Week Low
$10.16
52 Week High
$10.85
P/E
82.38x
P/B
-22.88x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$16.39M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.11
Operating Cash Flow
-$18M
Beta
0.02
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
CVII Overview
Churchill Capital Corp VII is a "blank check" company formed to effect mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations. It targets any business or industry. The company was incorporated in 2020 and is based in New York, NY.
Zen Score
–
Industry Average (8)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CVII scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CVII was unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CVII is poor value based on its earnings relative to its share price (82.38x), compared to the US market average (41.92x)
P/E vs Market Valuation
CVII is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more CVII due diligence checks available for Premium users.
Be the first to know about important CVII news, forecast changes, insider trades & much more!
CVII News
Valuation
CVII price to earnings (PE)
For valuing profitable companies with steady earnings
Company
82.38x
Industry
35.77x
Market
41.92x
CVII is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CVII is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
CVII price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-22.88x
Industry
-14.4x
CVII's financial health
Profit margin
Revenue
$0.0
Net Income
$15.8M
Profit Margin
0%
CVII's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$617.0M
Liabilities
$47.7M
Debt to equity
-1.11
CVII's short-term liabilities ($21.93M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CVII's long-term liabilities ($25.78M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CVII's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CVII's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$2.1M
Investing
$1.9M
Financing
$3.0M
CVII's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
CVII vs Shell Company Stocks
Churchill Capital Vii Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.